GILD
Gilead Sciences, Inc.
NASDAQ · USHealthcareDrug Manufacturers - General
$133.21-0.80%
Price as of Jul 20, 2026
GILD capital
Gilead Sciences, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.94x
- Net debt / equity
- 0.62x
- Debt / assets
- 0.39x
- Debt / EBITDA
- 1.58x
- Net debt / EBITDA
- 1.04x
Liquidity & coverage
- Current ratio
- 1.97x
- Quick ratio
- 1.77x
- Cash ratio
- 1.04x
- Interest coverage
- 11.32x
- EBITDA / interest
- 13.95x
- Working capital
- $9.2B
Cash & dividend
- FCF / debt
- 0.46x
- Cash flow / debt
- 0.49x
- Dividend per share
- $1.64
- Dividend yield
- 1.2%
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.